Coe Mary Ellen 4

What Happened

• Mary Ellen Coe, a director of Merck & Co., received an award of 233.463 phantom stock units (derivative securities) on 2026-06-30. The units were valued using $128.50 per share, for a total grant value of $30,000. This transaction is coded as an award/grant (A) rather than an open-market purchase.

Key Details

• Transaction date: 2026-06-30; filing date (Form 4): 2026-07-01 (timely).
• Units granted: 233.463 phantom stock units; price used: $128.50; total reported value: $30,000.
• Instrument type: derivative (phantom stock units), not actual common shares.
• Shares/units owned after transaction: not specified in the filing.
• Footnotes: F1 indicates a 1-for-1 relationship (units correspond to one share each). F2 states phantom units will be settled 100% in cash upon the reporting person's termination of service per the director deferred compensation plan.
• Transaction code: A (award/grant).

Context

• Phantom stock units are a form of deferred compensation that track the economic value of shares but are typically settled in cash (here, upon termination). Such awards are compensation-related and do not represent an immediate purchase of common stock or a direct vote of market sentiment.